nortriptyline has been researched along with Day Blindness in 3 studies
Nortriptyline: A metabolite of AMITRIPTYLINE that is also used as an antidepressive agent. Nortriptyline is used in major depression, dysthymia, and atypical depressions.
nortriptyline : An organic tricyclic compound that is 10,11-dihydro-5H-dibenzo[a,d][7]annulene substituted by a 3-(methylamino)propylidene group at position 5. It is an active metabolite of amitriptyline.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asberg, M | 2 |
| Germanis, M | 1 |
| Pigott, PV | 1 |
3 trials available for nortriptyline and Day Blindness
| Article | Year |
|---|---|
Ophthalmological effects of nortriptyline--relationship to plasma level.
Topics: Accommodation, Ocular; Adult; Aged; Clinical Trials as Topic; Depression; Female; Humans; Male; Midd | 1972 |
A review of clinical studies with combinations of fluphenazine and nortriptyline.
Topics: Amitriptyline; Anxiety; Central Nervous System; Clinical Trials as Topic; Depression; Diazepam; Doxe | 1972 |
Plasma nortriptyline levels--relationship to clinical effects.
Topics: Adjustment Disorders; Antidepressive Agents; Blood Proteins; Clinical Trials as Topic; Depression; D | 1974 |